Extended ECG Monitoring in HCM Patients

Inclusion Criteria:

Subject must be 18 to 65 years of age at time of informed consent and must not be a member of a vulnerable population.
Subject has been diagnosed with hypertrophic cardiomyopathy, as defined by a maximal LV wall thickness of ≥15 mm anywhere in LV wall, in absence of another cause that could be responsible for the LV hypertrophy.
Subject eligible to receive the Zio XT device per the current approved indications for use.

Exclusion Criteria:

Subject with pacemaker
Known skin allergies or reaction to adhesives
The investigator deems a condition that could limit a subject's ability or unwillingness to participate in the study, comply with study required monitoring and/or follow-up visits.